Antibacterial compounds
US-9428474-B2 · Aug 30, 2016 · US
US9758497B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9758497-B2 |
| Application number | US-201615231389-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 8, 2016 |
| Priority date | Dec 21, 2012 |
| Publication date | Sep 12, 2017 |
| Grant date | Sep 12, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the following compounds for use in the treatment of a bacterial infection wherein the integers are as defined in the description. The invention also relates to compounds for use as medicaments, pharmaceutical compositions and some novel compounds.
Opening claim text (preview).
The invention claimed is: 1. A compound selected from the group consisting of: and pharmaceutically acceptable salts thereof. 2. A pharmaceutical composition comprising a compound as claimed in claim 1 and a pharmaceutically acceptable carrier.
for tuberculosis · CPC title
Antibacterial agents · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
condensed with carbocyclic rings · CPC title
condensed with carbocyclic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.